|
Clinicopathological
| |
n
|
mean ± SD
|
p value
|
|---|
|
Tissue
|
Adjacent non-cancerous tissue
|
43
|
5.2775 ± 1.64708
|
< 0.001*
|
|
LUAD
|
445
|
2.8959 ± 1.35967
|
|
Age (years)
|
< 60
|
120
|
3.0042 ± 1.40207
|
0.168
|
|
≥60
|
306
|
2.7979 ± 1.33460
|
|
Gender
|
Female
|
239
|
2.9011 ± 1.33672
|
0.931
|
|
Male
|
206
|
2.8898 ± 1.38905
|
|
Tumor location
|
Central lung
|
54
|
2.5665 ± 1.1857
|
0.382
|
|
Peripheral lung
|
113
|
2.747 ± 1.3564
|
|
Stage
|
Stage I-II
|
349
|
2.8191 ± 1.33042
|
0.031*
|
|
Stage III-IV
|
91
|
3.1868 ± 1.45395
|
|
T
|
T1-T2
|
385
|
2.9199 ± 1.35515
|
0.133
|
|
T3-T4
|
57
|
2.6359 ± 1.3106
|
|
N
|
No
|
291
|
2.8546 ± 1.35977
|
0.553
|
|
Yes
|
145
|
2.9367 ± 1.35784
|
|
M
|
No
|
283
|
2.8058 ± 1.31875
|
0.126
|
|
Yes
|
19
|
3.3343 ± 1.4003
|
- SD Standard deviation, LUAD Lung adenocarcinoma
- *p < 0.05 was considered statistically significant
